Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener Medizinische Wochenschrift 1-2/2021

14.12.2020 | short report

SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms

verfasst von: Professor of Infectious Diseases Masoomeh Sofian, Professor of Pediatrics Ali Akbar Velayati, Professor of Pediatrics Mohammad Banifazl, Associate Professor of Virology Fatemeh Fotouhi, PhD Mona Sadat Larijani, Master degree of Government Management Neda Afzali, MD, PhD Amitis Ramezani

Erschienen in: Wiener Medizinische Wochenschrift | Ausgabe 1-2/2021

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), as the causative agent of the ongoing pandemic, has spread into more than 200 countries to date. The disease which is caused by the virus is termed COVID-19. In most cases, it presents at first like common flu with cough and other respiratory symptoms. Nevertheless, other symptoms have been reported, such as a feeling of extreme fatigue, gastrointestinal symptoms, or acute onset of olfactory and gustatory dysfunction. Here we report a series of 10 cases (1 male, 9 females) observed between February and April 2020, with an undulating appearance and disappearance of symptoms. Weeks passed before the diagnosis was established. Symptoms resolved rapidly after treatment with hydroxychloroquine. It seems that the course of COVID-19 can be mild or moderate but with a long persistence of symptoms, and may therefore remain obscure. This may cause a public health issue because of the long infectivity of these patients.
Literatur
1.
Zurück zum Zitat Chan JF‑W, Kok K‑H, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221–36. CrossRef Chan JF‑W, Kok K‑H, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect. 2020;9(1):221–36. CrossRef
2.
Zurück zum Zitat Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–207. CrossRef Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel Coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199–207. CrossRef
4.
Zurück zum Zitat Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S‑Y. Pulmonary pathology of early-phase 2019 novel Coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15(5):700–4. CrossRef Tian S, Hu W, Niu L, Liu H, Xu H, Xiao S‑Y. Pulmonary pathology of early-phase 2019 novel Coronavirus (COVID-19) pneumonia in two patients with lung cancer. J Thorac Oncol. 2020;15(5):700–4. CrossRef
6.
Zurück zum Zitat Heymann DL. Data sharing and outbreaks: best practice exemplified. Lancet. 2020;395(10223):469–70. CrossRef Heymann DL. Data sharing and outbreaks: best practice exemplified. Lancet. 2020;395(10223):469–70. CrossRef
7.
Zurück zum Zitat Zhou P, Yang X‑L, Wang X‑G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. CrossRef Zhou P, Yang X‑L, Wang X‑G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–3. CrossRef
8.
Zurück zum Zitat Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus—Infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9. CrossRef Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus—Infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–9. CrossRef
9.
Zurück zum Zitat Dhama K, Sharun K, Tiwari R, et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother. 2020;16(6):1232–8. CrossRef Dhama K, Sharun K, Tiwari R, et al. COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics. Hum Vaccin Immunother. 2020;16(6):1232–8. CrossRef
10.
Zurück zum Zitat Kumar S, Poonam, Rathi B. Coronavirus disease COVID-19: a new threat to public health. Curr Top Med Chem. 2020;20(8):599–600. CrossRef Kumar S, Poonam, Rathi B. Coronavirus disease COVID-19: a new threat to public health. Curr Top Med Chem. 2020;20(8):599–600. CrossRef
13.
Zurück zum Zitat Chen L, Liu H, Liu W, et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E5. PubMed Chen L, Liu H, Liu W, et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43:E5. PubMed
15.
Zurück zum Zitat Zhu N, Zhang D, Wang W, et al. A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. CrossRef Zhu N, Zhang D, Wang W, et al. A novel Coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33. CrossRef
16.
Zurück zum Zitat Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. CrossRef Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. CrossRef
17.
Zurück zum Zitat Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13. CrossRef Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–13. CrossRef
18.
Zurück zum Zitat Walls AC, Park Y‑J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-coV‑2 spike glycoprotein. Cell. 2020;181(2):281–292.e6. CrossRef Walls AC, Park Y‑J, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-coV‑2 spike glycoprotein. Cell. 2020;181(2):281–292.e6. CrossRef
19.
Zurück zum Zitat Ahrends T, Busselaar J, Severson TM, et al. CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities. Nat Commun. 2019;10(1):5531. CrossRef Ahrends T, Busselaar J, Severson TM, et al. CD4+ T cell help creates memory CD8+ T cells with innate and help-independent recall capacities. Nat Commun. 2019;10(1):5531. CrossRef
20.
Zurück zum Zitat Shi Y, Wang Y, Shao C, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27(5):1451–4. CrossRef Shi Y, Wang Y, Shao C, et al. COVID-19 infection: the perspectives on immune responses. Cell Death Differ. 2020;27(5):1451–4. CrossRef
21.
Zurück zum Zitat Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV‑2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027–34. CrossRef Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV‑2 in patients of novel coronavirus disease 2019. Clin Infect Dis. 2020;71(16):2027–34. CrossRef
23.
Zurück zum Zitat Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV‑2. Signal Transduct Target Ther. 2020;5(1):84. CrossRef Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S, Lanni C. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV‑2. Signal Transduct Target Ther. 2020;5(1):84. CrossRef
25.
Zurück zum Zitat Siracusano G, Pastori C, Lopalco L. Humoral immune responses in COVID-19 patients: a window on the state of the art. Front Immunol. 2020;11:1049. CrossRef Siracusano G, Pastori C, Lopalco L. Humoral immune responses in COVID-19 patients: a window on the state of the art. Front Immunol. 2020;11:1049. CrossRef
Metadaten
Titel
SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms
verfasst von
Professor of Infectious Diseases Masoomeh Sofian
Professor of Pediatrics Ali Akbar Velayati
Professor of Pediatrics Mohammad Banifazl
Associate Professor of Virology Fatemeh Fotouhi
PhD Mona Sadat Larijani
Master degree of Government Management Neda Afzali
MD, PhD Amitis Ramezani
Publikationsdatum
14.12.2020
Verlag
Springer Vienna
Erschienen in
Wiener Medizinische Wochenschrift / Ausgabe 1-2/2021
Print ISSN: 0043-5341
Elektronische ISSN: 1563-258X
DOI
https://doi.org/10.1007/s10354-020-00793-8